Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | FEN1 | P39748 | 5/20 | 0.41 |
| ▸ | ALOX5AP | P20292 | 4/20 | 0.41 |
| ▸ | HMOX1 | P09601 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26075411 | 0.90 | HMOX1 (0.42) | MEN1KMT2AHPGDFEN1ALOX5AP | |
| SCHEMBL26075292 | 0.90 | FEN1 (0.41) | PTGS2MAPTMEN1KMT2AHPGD | |
| SCHEMBL26075134 | 0.88 | PTGS2 (0.47) | PTGS2MAPTMEN1KMT2ANPSR1 | |
| SCHEMBL26075595 | 0.88 | MAP4K4 (0.45) | MAPTMEN1KMT2ANPSR1TDP1 | |
| SCHEMBL23590134 | 0.87 | KDM4E (0.52) | PTGS2MEN1KMT2ATDP1HPGD | |
| SCHEMBL26075876 | 0.87 | PTGS2 (0.45) | PTGS2MAPTMEN1KMT2ANPSR1 | |
| SCHEMBL26075393 | 0.84 | PDE10A (0.43) | MAPTFEN1ALOX5APTP53 | |
| SCHEMBL26075920 | 0.83 | ACP1 (0.44) | MAPTNPSR1FEN1ALOX5APLMNA | |
| SCHEMBL26075385 | 0.83 | FEN1 (0.39) | PTGS2MAPTFEN1ALOX5APLMNA | |
| SCHEMBL26075973 | 0.83 | FEN1 (0.39) | FEN1ALOX5APLMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303710-A1 | METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT | OHIO STATE INNOVATION FOUNDATION (US) | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303710-A1 | METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT | DHODH, CD38, DPYD | PTGS2 2496/4885MAPT 2689/4885MEN1 2373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.